06:03 EST Alto Neuroscience (ANRO) files to sell 8.45M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANRO:
- Alto Neuroscience initiated with a Buy at BTIG
- Alto Neuroscience, Inc.: Promising Future with Strategic Advancements and Strong Financial Position
- Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Innovative Treatment Prospects
- Alto Neuroscience price target raised to $22 from $16 at Baird
- Promising Future for Alto Neuroscience: Buy Rating Backed by Strong Financials and Clinical Advancements